Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. The oncology franchise includes both marketed products and clinical development compounds which reflect the company’s approach to research: prioritizing targets and pathways with the potential to impact the way that cancer is treated.